PT Kalbe Farma Tbk (ISX:KLBF) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:KLBF PT Kalbe Farma Tbk ISX:KLBF
77 GF Score
Price Rp725.00
GF Value Rp1,756.38
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is PT Kalbe Farma Tbk FFO?

FFO (Funds from operations) only applies to REITs.

ISX:KLBF
77GF Score
PT Kalbe Farma Tbk ISX:KLBF
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is PT Kalbe Farma Tbk (ISX:KLBF) Overvalued in 2026?

Based on GuruFocus' analysis, PT Kalbe Farma Tbk stock appears to be undervalued. The current stock price of Rp725.00 is trading 58.7% below its estimated GF Value™ of Rp1,756.38. GuruFocus considers PT Kalbe Farma Tbk to be Significantly Undervalued.

Key valuation signals for ISX:KLBF:

  • FFO:
  • GF Value™: Rp1,756.38 vs. price of Rp725.00 (58.7% below fair value)
  • GF Score™: 77/100 with 2 warning signs

No single metric tells the full story. See the ISX:KLBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PT Kalbe Farma Tbk Business Description

Address Jalan Let. Jend. Suprapto Kav. 4, Gedung KALBE, Cempaka Putih, P.O. Box 3105, Jakarta, IDN, 10510
PT Kalbe Farma Tbk is engaged in the development, manufacturing, and trading of pharmaceutical products, including human medicines and consumer health products. The company operates four segments: prescription pharmaceuticals, consumer health, Nutritionals, and distribution and logistics. The majority of the company's revenue is derived from the distribution and logistics segments. Its Product and Services are Prescription /Ethicals, Consumer Health, Nutritionals, Distribution & Logistics, Health Services, Medical Devices, and Others.
77GF Score

Get the complete analysis for ISX:KLBF

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp725.00
Price
Rp1,756.38
GF Value